CURRICULUM VITAE
Texas A&M Health Science Center (TAMU 1266)
E-ma EDUCATION: University of Houston, Houston, Texas
Professor, Department of Health Policy and Management, College of Rural Public Health, Texas A&M Health Science Center, College Station, Texas.
Scientific Advisor, U.S. Health Economics, Oxford Outcomes, Ltd., Morristown, New Jersey.
Professor, Department of Health Management and Policy, College of Public Health, University of Iowa, Iowa City.
Senior Scientist and Core Investigator, Center for Research in the Implementation of Innovative Strategies in Practice (CRIISP), Iowa City Veterans Affairs Medical Center, Iowa City.
Health Outcomes Research Scientist, Health Outcomes Evaluation Group, U.S. Medical Division, Eli Lilly and Company, Indianapolis, Indiana.
Adjunct Professor, College of Pharmacy, Butler University, Indianapolis, Indiana.
Adjunct Professor, School of Public and Environmental Affairs, Indiana University, Indianapolis.
Professor, Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham (primary).
Associate Professor, Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham (primary).
Professor/Associate Professor, Department of Health Administration, School of Health-Related Professions, and Department of Economics, School of Business, UAB (secondary).
Senior Scholar/Scholar, Lister Hill Center for Health Policy, UAB (secondary).
Senior Scientist/Scientist, Injury Control Research Center, UAB (secondary).
Assistant Professor, School of Health Administration and Policy, College of Business, Arizona State University, Tempe, Arizona.
Research Economist, Center for Health Policy Research, American Medical Association, Chicago, Illinois.
Assistant Professor of Economics, College of Business, Ball State University, Muncie, Indiana.
Visiting Assistant Professor of Economics, College of Business, Louisiana Tech University, Ruston, Louisiana.
Research Associate, Southwest Center for Urban Research, Houston, Texas.
Research Assistant and Teaching Fellow, Department of Economics, College of Social Sciences, University of Houston.
HONORS AND AWARDS: President’s Award, Lilly Research Laboratories, Eli Lilly and Company, 2001. Faculty Research Development Award, Arizona State University, 1989. Robert Wood Johnson Foundation Faculty Fellowship in Health Care Finance, Johns Hopkins University,
EDITORIAL/ADVISORY BOARDS: Editorial Advisory Board, Journal of Managed Care Pharmacy [2005 - ] Associate Editor, Open Pharmacoeconomics & Health Economics Journal [2008 - ] Member (ad hoc), Special Emphasis Review Panel, Economics of Prevention, Center for Scientific Review,
Member (ad hoc), Special Emphasis Review Panel, Sustainable Community-Linked Infrastructure Panel 2,
Member (ad hoc), Special Emphasis Review Panel, Smokeless Tobacco Use Cessation, National Cancer
Member (ad hoc), Community Influences on Health Behavior Study Section (formerly Community-Level
Health Promotion/SNEM-1), Center for Scientific Review, National Institutes of Health [2003-09 ]
Member (ad hoc), Special Emphasis Review Panel, Center for Scientific Review, National Institutes of Health
Member, Small Grant Program Science Review Committee, Health Services Research and Development
Service, U.S. Department of Veterans Affairs [1992-96]
Member, Science Review Committee, Health Services Research and Development Service, U.S. Department
Member, Ad Hoc Review Committee, Dissertation Research Grant Program, Agency for Health Care Policy
MEMBER: Academy of Managed Care Pharmacy American Society of Health Economists International Health Economics Association International Society for Pharmacoeconomics and Outcomes Research PUBLICATIONS (Peer Reviewed): Schneider, J.E., Li, P., and Ohsfeldt, R.L., “The Effects of Endogenous Market Entry of Physician-Owned
Hospitals on Medicare Expenditures: An Instrumental Variables Approach,” Contemporary Economic Policy (forthcoming).
Vest, J.R., Zhao, H., Jasperson, J., Gamm, L.D., and Ohsfeldt, R.L., “Factors Motivating and Affecting
Health Information Exchange Usage,” Journal of the American Medical Informatics Association, (forthcoming).
Wolinsky, F., Bentler, S., Liu, L., Jones, M., Kaskie, B., Hockenberry, J., Chrischilles, E., Wright, K.,
Geweke, J., Obrizan, M., Ohsfeldt, R., Rosenthal, G., and Wallace, R., “Prior Hospitalization and the Risk of Heart Attack in Older Adults: A 12-year Prospective Study of Medicare Beneficiaries,” Journal of Gerontology: Medical Sciences (forthcoming).
Ohsfeldt, R.L., Gandhi, S.K., Fox, K.M., Bullano, M.F., and Davidson, M., “Medical and Cost Burden of
Atherosclerosis among Patients Treated in Routine Clinical Practice,” Journal of Medical Economics (forthcoming).
Weigel, P., Hockenberry, J., Bentler, S., Obrizan, M., Kaskie, B., Jones, M., Ohsfeldt, R., Rosenthal, G.,
Wallace, R. and Wolinsky, F., “A Longitudinal Study of Chiropractic Use Among Older Adults in the United States,” Chiropractic & Osteopathy 18 [December 2010]: 34 (1-14).
Ohsfeldt, R.L., Gandhi, S.K., Smolen, L., Jensen, M., Fox, K.M., Gold, A., and Hsia, J., “Cost-effectiveness
of Rosuvastatin in Patients at Risk of Cardiovascular Disease Based on Findings from the JUPITER Trial,” Journal of Medical Economics 13 [July 2010]: 428–437.
Kaskie, B., Obrizan, M., Cook, E., Jones, M., Liu, L., Bentler, S., Wallace, R., Geweke, J., Wright, K.,
Chrischilles, E., Pavlik, C., Ohsfeldt, R., Rosenthal, G., and Wolinsky, F., “Defining Emergency Department Episodes by Severity and Intensity: A 15-year Study of Medicare Beneficiaries,” BMC Health Services Research 10 [June 2010]: 173.
Wolinsky, F., Bentler, S., Liu, L., Geweke, J., Cook, E., Obrizan, M., Chrischilles, E., Wright, K., Jones, M.,
Rosenthal, G., Ohsfeldt, R., and Wallace R., “Continuity of Care with a Primary Care Physician and Mortality in Older Adults,” Journal of Gerontology: Medical Sciences 65A [April 2010]: 442-449.
McKenney, J.M., Gandhi, S.K., Fox, K.M., and Ohsfeldt, R.L., “Atherosclerosis in a Managed Care Plan:
Hypercholesterolemia Treatment Patterns and Low-Density Lipoprotein Cholesterol Monitoring,” Journal of Clinical Lipidology 6 [December 2009]: 385-392.
Bentler, S., Liu, L., Obrizan, M., Cook, E., Wright, K., Geweke, J., Chrischilles, E., Plavik, C., Wallace, R.,
Ohsfeldt, R., Jones, M., Rosenthal, G., and Wolinsky, F., “The Aftermath of Hip Fracture: Discharge Placement, Functional Status Change, and Mortality,” American Journal of Epidemiology 170 [November 2009]: 1290-1299.
Wehby, G., Murray, J., Castilla, E., Lopez-Camelo, J., and Ohsfeldt, R. "Quantile Effects of Prenatal Care
Utilization on Birth Weight in Argentina," Health Economics 18 [November 2009]: 1307-1321.
Davidson, M., Fox, K., Gandhi, S., Ohsfeldt, R., and McKenney, J., “Medical Management of Patients Prior
to the Incidence of a Cardiovascular Event,” Journal of Clinical Lipidology 3 [October 2009]: 315-321.
Ohsfeldt, R.L., Gandhi, S.K., Fox, K.M., and McKenney, J.M., “Medicare-eligible Patients Diagnosed with
Atherosclerosis: Unmet Need in Hypercholesterolemia Treatment and Lipid Monitoring.” Current Medical Research and Opinion 25 [May 2009]: 1403-1411.
Wolinsky, F., Bentler, S., Cook, E., Chrischilles, E., Liu, L., Wright, K., Geweke, J., Obrizan, M., Plavik, C.,
Ohsfeldt, R., Jones, M., Wallace, R., and Rosenthal, G., “A 12-Year Prospective Study of Stroke Risk in Older Medicare Beneficiaries,” BMC Geriatrics 9 [May 2009]: 17.
Wehby, G., Murray, J., Castilla, E., Lopex-Camelo, J., and Ohsfeldt, R., “Prenatal Care Effectiveness and
Utilization in Brazil,” Health Policy and Planning 24 [May 2009]: 175-188.
Rautiainen, L., Ledolter, J., Ohsfeldt, R., Donham, K., and Zwerling, C., "Risk Factors for Serious Injury in
Finnish Agriculture," American Journal of Industrial Medicine 52 [May 2009]: 419-428.
Wehby, G., Murray, J., Castilla, E., Lopez-Camelo, J., and Ohsfeldt, R., “Prenatal Care Demand and Its
Effects on Birth Outcomes by Birth Defect Status in Argentina,” Economics and Human Biology 7 [March 2009]: 84-95.
Wolinsky, F., Liu, L., Miller, R., An, H., Geweke, J., Ohsfeldt, R., Kaskie, B., Wright, K., Chrischilles, E.,
Pavlin, C., Cook, E., Richardson, K., Rosenthal, G., and Wallace, R., "Recent Hospitalization and the Risk of Hip Fracture among Older Americans," Journal of Gerontology: Medical Sciences 64A [February 2009]: 249-255.
Kash, B.A., Ohsfeldt, R.L., and Gamm, L.D., “An Attempt to Forecast Hospital Market Share using
Admission Data,” Journal of Healthcare Management 54 [Jan/Feb 2009]: 44-56.
Davidson, M.H., Gandhi, S.K., Ohsfeldt, R.L., and Fox, K.M., “Hypercholesterolemia Treatment Patterns and
Low-Density Lipoprotein Cholesterol Monitoring among Patients with a Diagnosis of Atherosclerosis in Clinical Practice,” American Journal of Medicine 122 [January 2009]: S51-S59.
Ohsfeldt, R.L., Gandhi, S.K., Fox, K.M., and McKenney, J.M., “Statin Cost-effectiveness Comparisons Using
Real-world Effectiveness Data: Formulary Implications,” Value in Health 11 [December 2008]: 1061-1069.
Schneider, J.E., Miller, T.R., Ohsfeldt, R.L., Morrisey, M.A., Zelner, B.A., and Li, P., “The Economics of
Specialty Hospitals,” Medical Care Research and Review 65 [October 2008]: 531-553.
Udeh, B., Schneider, J.E., and Ohsfeldt, R.L., “Cost Effectiveness Analysis of a Point-of-Care Test for
Adenoviral Conjunctivitis,” American Journal of Medical Sciences 336 [September 2008]: 254-264.
Wehby, G.L., Ohsfeldt, R.L., and Murray, J.C., “Mendelian Randomization Equals Instrumental Variable
Analysis with Genetic Instruments, Statistics in Medicine 27 [July 10, 2008]: 2745-2749.
Wolinsky, F., Liu, L., Miller, R., An, H., Geweke, J., Kaskie, B., Wright, K., Chrischilles, E., Pavlin, C.,
Cook, E., Ohsfeldt, R., Richardson, K., Rosenthal, G., and Wallace, R., “Emergency Department
Utilization Patterns Among Older Adults,” Journal of Gerontology: Medical Sciences 63A [February 2008]: 204-209.
Wehby, G.L. and Ohsfeldt, R.L., “Impact of Having a Young Child with Disabilities on Maternal Labor
Supply,” Journal of Health and Human Services Administration 30 [Winter 2007]: 327-351.
Fox, K.M, Gandhi, S.K., and Ohsfeldt, R.L., “Comparison of Low Density Lipoprotein-Cholesterol (LDL-C)
Reduction after Switching Patients on Other Statins to Rosuvastatin or Simvastatin in a Real-World Clinical Practice Setting,” American Journal of Managed Care 13 [December 2007]: S270-S275.
Fox, K.M., Gandhi, S.K., Ohsfeldt, R.L., Blasetto, J.W., and Davidson, M.H., “Titration Patterns with
Rosuvastatin as Compared to Other Statins in Clinical Practice: Retrospective Cohort Study Using an Electronic Medical Record Database,” Clinical Therapeutics 29 [November 2007]: 2385-2394.
Schneider, J.E., Ohsfeldt, R.L., Li, P., Miller, T.R., Morrisey, M.A. and Zelner, B.A., “The Effects of
Specialty Hospitals on General Hospital Financial Performance, 1997-2004,” Inquiry 44 [Fall 2007]: 321-334.
Fox, K.M, Gandhi, S.K., Ohsfeldt, R.L., Blasetto, J.W., and Davidson, M.H., “Effectiveness of Statins in
Medicare-eligible Patients and Patients <65 Years using Clinical Practice Data,” International Journal of Clinical Practice 61 [October 2007]: 1634-1642.
Wolinsky, F., Lui, L., Miller, T., Geweke, J., Cook, E., Greene, B., Wright, K., Chrischilles, E., Pavlik, C.,
An, H., Ohsfeldt, R., Richardson, K., Rosenthal, G., and Wallace, R., “The Use of Chiropractors by Older Adults in the United States,” Chiropractic & Osteopathy 15 [September 6, 2007]: 1-9.
Fox, K.M., Gandhi, S.K., Ohsfeldt, R.L., Blasetto, J.W., and Bays, H.E., “Effectiveness of Statins in Low-
density Lipoprotein Cholesterol Lowering and National Cholesterol Education Program Adult Treatment Panel Guideline III LDL-C Goal Attainment among Diabetes Mellitus Patients: A U.S. Retrospective Analysis,” Current Medical Research and Opinion 23 [September 2007]: 2125-2133.
Ohsfeldt, R.L., Lage, M.J., and Rajagopalan, K., “Medication Use, Service Utilization and Medical Costs
Associated with New Episodes of Bipolar Disorder: Evidence from a Retrospective, Claims Database,” Primary Care Companion to the Journal of Clinical Psychiatry 9 [August 2007]: 280–286.
Wolinsky, F., Miller, T., Geweke, J., Chrischilles, E., An, H., Wallace, R., Pavlik, C., Wright, K., Ohsfeldt,
R., and Rosenthal, G., “An Interpersonal Continuity of Care Measure for Medicare Part B Claims Analyses,” Journals of Gerontology: Social Sciences 62B [May 2007]: S160-S168.
Meadows, E., Rousculp, M., Klein, R., Ohsfeldt, R., and Johnston, J.A., “Cost-Effectiveness of
Pharmacological Treatment for Osteopenia in Postmenopausal Women,” BMC Women’s Health 7 [April 17, 2007]: 1-9.
Wolinsky, F., Miller, T., An, H., Geweke, J., Wallace, R.,Wright, K., Chrischilles, E., Liu, L., Pavlik, C.,
Cook, E., Ohsfeldt, R., Richardson, K., and Rosenthal, G., "Hospital Episodes and Physician Visits in the AHEAD Cohort: The Concordance Between Self-Reports and Medicare Claims," Medical Care 45 [April 2007]: 300-307.
Schneider, J.E. and Ohsfeldt, R.L., “The Role of Markets and Competition in Health Care Reform Initiatives
to Improve Efficiency and Enhance Access to Care,” Cumberland Law Review 37 [No.3 2006/2007]: 479-511.
Ohsfeldt, R.L., Gandhib, S., Fox, K., Stacy, T., and, McKenney, J., “Effectiveness and Cost-Effectiveness of
Rosuvastatin, Atorvastatin and Simvastatin among High Risk Patients in Usual Clinical Practice,” American Journal of Managed Care 12 [November 2006]: S412-S423.
Balamurugan, A., Ohsfeldt, R.L., Hughes, T., Phillips, M., “Diabetes Self-Management Education for
Medicaid Recipients: A Continuous Quality Improvement Process,” Diabetes Educator 32 [Nov/Dec 2006]: 893-900.
Wehby, G.L., Ohsfeldt, R.L. and Murray, J., “Health Professionals' Assessment of Health Related Quality of
Life Values for Oral Clefting by Age Using a Visual Analogue Scale Method,” Cleft Palate-Craniofacial Journal 43 [July 2006]: 383-391.
Ohsfeldt, R.L. Borisov, N.N., and Sheer, R.L., “Fragility Fracture-Related Medical Costs in the First Year
Following a Non-Vertebral Fracture in a Managed Care Setting,” Osteoporosis International 17 [February 2006]: 252-258.
Rautiainen, R., Ohsfeldt, R., Sprince, N., Donham, K., Burmeister, L., Reynolds, S., Saarimaki, P., and
Zwerling, C., “Cost of Compensated Injuries and Occupational Diseases in Agriculture in Finland,” Journal of Agromedicine 10 [No. 3, 2005]: 21-30.
Rautiainen, R., Ledolter, J., Sprince, N., Donham, K., Burmeister, L., Ohsfeldt, R., Reynolds, S., Phillips, K.,
Saarimaki, P., and Zwerling, C., “Effects of Premium Discount on Workers’ Compensation Claims in Agriculture in Finland,” American Journal of Industrial Medicine, 48 [August 2005]: 100-109.
Cram, P., Rosenthal, G., Ohsfeldt, R., Wallace, R., Schlechte, J., and Schiff, G., “Failure to Recognize and
Act on Abnormal Test Results: The Case of Screening Bone Densitometry,” Joint Commission Journal on Quality and Safety, 31 [February 2005]: 90-97.
Ohsfeldt, R.L., Ward, M.M., Schneider, J.E., Jaana, M., Miller, T.R., Lei, Y., and Wakefield, D.S.,
“Implementation of Hospital Computerized Physician Order Entry Systems in a Rural State: Feasibility and Financial Impact,” Journal of the American Medical Informatics Association, 12 [January/February 2005]: 20-27.
Ohsfeldt, R.L., “Estimating the Cost-Effectiveness of Alternative Treatments for Postmenopausal
Osteoporosis,” Expert Review of Pharmacoeconomics & Outcomes Research, 4 [December 2004]: 637-644.
Wakefield, D.S., Ward, M.M., Miller, T., Ohsfeldt, R.L. Janna, M., Lei, Y., Tracy, R., and Schneider, J.E.,
“ICU Utilization and Inter-Hospital Transfers as Potential Indicators of Rural Hospital Quality,” Journal of Rural Health, 20 [Fall 2004]: 394-400.
Ward, M.M, Jaana, M., Wakefield, D.S., Ohsfeldt, R.L., Schneider, J.E., Miller, T., and Lei, Y., “What
Would Be the Effect of Increased Referrals to High Volume Hospitals in a Rural State?” Journal of Rural Health, 20 [Fall 2004]: 344-54.
Ohsfeldt, R.L., Kreder, K.J., Klein, R.W., and Chrischilles, E.A., “Cost-Effectiveness of Tamsulosin,
Doxazosin, and Terazosin in the Treatment of Benign Prostatic Hyperplasia,” Journal of Managed Care Pharmacy, 10 [Sept/Oct 2004]: 412-422.
Ohsfeldt, R.L., Gavin, N.I., and Thorp, J., “Medical Care Costs Associated with Postmenopausal Estrogen
Plus Progestogen Therapy,” Value in Health, 7 [Sept/Oct 2004]: 544-553.
Morrisey, M.A., and Ohsfeldt, R.L., “Do State ‘Any Willing Provider’ and ‘Freedom of Choice’ Laws Affect
HMO Market Share?” Inquiry, 40 [Winter 2003/2004]: 362-374.
Grabowski, D.C., Ohsfeldt, R.L., and Morrisey, M.A., “The Effects of CON Repeal on Medicaid Nursing
Home and Long Term Care Expenditures,” Inquiry 40 [Summer 2003]: 146-157.
Mullins, C.D., and Ohsfeldt, R.L., “Modeling the Annual Costs of Postmenopausal Prevention Therapy Using
Hormone Replacement Therapy, Raloxifene, or Alendronate,” Journal of Managed Care Pharmacy, 9 [March/April 2003]: 150-158.
Ohsfeldt, R.L., O’Connor, L.C., Kemner, J.E., and Solomon, T., “Patterns of Physician-Reported Diagnoses
Among Women Receiving Prescriptions for Raloxifene,” American Journal of Health-System Pharmacy, 58 [October 1, 2001]: 1846-1849.
Gavin, N.I., Ohsfeldt, R.L., and Thorp, J.E., “Determinants of Hormone Replacement Therapy Duration
Among Postmenopausal Women with Intact Uteri,” Menopause, 8 [September 2001]: 377-383.
Thorp, J.E., Gavin, N.I., and Ohsfeldt, R.L., “Hormone Replacement Therapy in Postmenopausal Women:
Utilization of Health Care Resources in New Users,” American Journal of Obstetrics and Gynecology, 185 [August 2001]: 318-326.
Hoerger, T., Lakshmanan, M., Lindrooth, R., Plouffe, L., West, S., and Ohsfeldt, R.L., “Health Care Use
Among US Women Age 45 and Older: Total Costs and Costs for Selected Postmenopausal Risks,” Journal of Women’s Health & Gender-Based Medicine, 8 [October 1999]: 1077-1089.
Ohsfeldt, R.L., Boyle, R.C., and Capilouto, E.I., “Tobacco Taxes, Smoking Restrictions, and Tobacco Use,”
in The Economic Analysis of Substance Use and Abuse: An Integration of Econometric and Behavioral Economic Research, F.J. Chaloupka et al. (eds.), Chicago: University of Chicago Press, for the National Bureau of Economic Research [1999], Chapter 1, pp. 15-30. Also NBER Working Paper #6486 [March 1998].
Ohsfeldt, R.L., Morrisey, M.A., Nelson, L.J., and Johnson, V., “The Spread of State ‘Any Willing Provider’
Laws,” Health Services Research, 33 [December 1998, Part II]: 1537-1562.
Ohsfeldt, R.L., Boyle, R.C., and Capilouto, E.I., “Effects of Tobacco Excise Taxes on the Use of Smokeless
Tobacco Products in the US,” Health Economics, 6 [September/October 1997]: 525-531.
Chakravorty, B., Buchanan, R.J., and Ohsfeldt, R.L., “Coaches’ Perceptions of the NCAA’s Smokeless
Tobacco Policy and Athletes Who Use Smokeless Tobacco,” Applied Research in Coaching and Athletics Annual, 12 [1997]: 54-71.
Ohsfeldt, R.L. and Morrisey, M.A., “Beer Taxes, Workers' Compensation, and Industrial Injury Rates,”
Review of Economics and Statistics, 79 [February 1997]: 155-160.
Ohsfeldt, R.L., Morrisey, M.A., Johnson, V. and Treat, R., “Simplifying the Assessment of Rural EMS
Trauma Transport,” Medical Care, 34 [November 1996]: 1085-1092. Also published (inadvertently) in Medical Care, 34 [December 1996]: 1180-1187.
Morrisey, M.A., Ohsfeldt, R.L., Johnson, V. and Treat, R., “Trauma Patients: An Analysis of Rural
Ambulance Trip Reports,” Journal of Trauma, 41 [October 1996]: 741-746.
Morrisey, M.A., Ohsfeldt, R.L., Johnson, V. and Treat, R., “Rural Emergency Medical Services: Patients,
Destinations, Times, and Services,” Journal of Rural Health, 11 [Fall 1995]: 286-294.
Antel, J.J., Ohsfeldt, R.L., and Becker, E.R., “State Regulation and Hospital Cost Performance,” Review of Economics and Statistics, 77 [August 1995]: 416-422.
Gohmann, S.F. and Ohsfeldt, R.L., “Which States Will Restrict Abortions? Predictions from Votes in the
House of Representatives,” Policy Studies Review, 13 [Spring/Summer 1995]: 19-38.
Ohsfeldt, R.L. and Gohmann, S.F., “Abortion Policy and Infant Health: A Simulation Model of the Impact of
Hypothetical State Laws Proscribing Abortion Services,” Forum for Social Economics, 24 [Spring 1995]: 11-29.
Capilouto, E.I., Capilouto, M.L., and Ohsfeldt, R.L., “A Review of Methods Used to Project the Future
Supply of Dental Personnel and the Future Demand and Need for Dental Services,” Journal of Dental Education, 59 [January 1995]: 237-257.
Ohsfeldt, R.L. and Boyle, R.C., “Tobacco Excise Taxes and Rates of Smokeless Tobacco Use in the United
States: An Exploratory Ecological Analysis,” Tobacco Control, 4 [Winter 1994]: 316-323.
Gohmann, S.F. and Ohsfeldt, R.L., “The Dependent Tax Exemption, Abortion Availability, and U.S.
Fertility,” Population Research and Policy Review, 13 [1994]: 367-381.
Gohmann, S.F. and Ohsfeldt, R.L., “Voting in the U.S. House on Abortion Funding Issues: The Role of
Legislators' and Constituents' Ideology, Before and After the Webster Decision,” American Journal of Economics and Sociology, 53 [October 1994]: 455-474.
Clemmer, R., Kenkel, D., Ohsfeldt, R., and Webb, W., “Household Health Production, Property Values, and
the Value of Health,” in Health Values for Policy: An Economic Approach, G. Tolley, D. Kenkel, and R. Fabian (eds.), Chicago: University of Chicago Press [1994], Chapter 5, pp. 105-117.
Ohsfeldt, R.L. and Gohmann, S.F., “Do Parental Involvement Laws Reduce Adolescent Abortion Rates?”
Contemporary Economic Policy, 12 [April 1994]: 65-76.
Gohmann, S.F. and Ohsfeldt, R.L., “U.S. Senate Voting on Abortion: A More Direct Test For Ideological
Shirking,” in Research in Law and Economics, Volume 16, R. Zerbe and V. Goldberg (eds.), Greenwich, Connecticut: JAI Press [1994]: 176-196.
Buchanan, R.J. and Ohsfeldt, R.L., “The Attitudes of State Legislators and State Medicaid Policies for AIDS-
Related Care,” Policy Studies Journal, 21 [Winter 1993]: 651-671.
Gohmann, S.F. and Ohsfeldt, R.L., “The Effects of Price and Availability on Abortion Demand,”
Contemporary Policy Issues, 11 [October 1993]: 42-55.
Ohsfeldt, R.L., “Contractual Arrangements, Financial Incentives, and Physician-Patient Relationships,” in
Sociomedical Perspectives on Patient Care Relationships, J. Clair and R. Allman (eds.), Lexington, Kentucky: University Press of Kentucky [1993], Chapter 6, pp. 96-113.
Ohsfeldt, R.L. and Morrisey, M.A., “Firearms, Firearm Injury, and Gun Control: A Critical Review of the
Literature,” in Advances in Health Economics and Health Services Research, Volume 13, L. Rossiter and R. Scheffler (eds.), Greenwich, Connecticut: JAI Press [1992], pp. 65-82.
Ohsfeldt, R.L. and Gohmann, S.F., “The Economics of A ID S-Related Health Insurance Regulations: Interest
Group Influence and Ideology,” Public Choice, 74 [July 1992]: 105-26.
Buchanan, R.J., Ohsfeldt, R.L., Tobias, D., Tiffany, J., and Ziegler, J., “Medicaid Coverage of AIDS-Related
Care: Attitudes of State Legislators Serving on Health-Related Committees,” AIDS & Public Policy Journal, 6 [Number 3, 1991]: 135-41.
Ohsfeldt, R.L., Antel, J.J., and Buchanan, R.J., “The Effects of Prospective Payment Methods on Medicaid
Payment Rates for Nursing Home Care,” Southern Economic Journal, 58 [July 1991]: 54-64.
Lanning, J., Morrisey, M.A., and Ohsfeldt, R.L., “Endogenous Hospital Regulation and Its Effects on
Hospital and Non-hospital Expenditures,” Journal of Regulatory Economics, 2 [July 1991]: 137-54.
Buchanan, R.J., Cappelleri, J.C., and Ohsfeldt, R.L., “The Social Environment and Medicaid: Factors
Influencing the Level of State Medicaid Expenditures,” Public Administration Review, 51 [January/February 1991]: 67-73.
Gohmann, S.F. and Ohsfeldt, R.L., “Medicaid Payment Rates for Nursing Home Care, 1979-86,” Health Care Financing Review, 12 [Winter 1990]: 55-66.
Gohmann, S.F. and Ohsfeldt, R.L., “Predicting State Abortion Legislation from U.S. Senate Votes: The
Effects of Apparent Ideological Shirking,” Policy Studies Review, 9 [Summer 1990]: 749-64.
Morrisey, M.A., Alexander, J., and Ohsfeldt, R.L., “Physician Integration Strategies and Hospital Output: A
Comparison of Rural and Urban Institutions,” Medical Care, 28 [July 1990]: 586-603.
Ohsfeldt, R.L. and Gohmann, S.F., “Societal Attitudes about AIDS and AIDS-Related Health Insurance
Regulations,” AIDS & Public Policy Journal, 4 [Number 3, 1989]: 159-63.
Ohsfeldt, R.L., “The Effect of AMA Membership on Physicians' Earnings,” Industrial and Labor Relations Review, 42 [October 1988]: 20-33.
Ohsfeldt, R.L., Culler, S.D., and Becker, E.R., “Sex Differences in the Economic Advantages of Physician
Board Certification,” Southern Economic Journal, 54 [October 1987]: 343-50.
Ohsfeldt, R.L. and Culler, S.D., “Differences in Income Between Male and Female Physicians,” Journal of Health Economics, 5 [December 1986]: 335-46.
Culler, S.D. and Ohsfeldt, R.L., “The Determinates of the Provision of Charity Medical Care by Physicians,”
Journal of Human Resources, 22 [Winter 1986]: 138-56.
Ohsfeldt, R.L., “Uncompensated Medical Services Provided by Physicians and Hospitals,” Medical Care, 23
Becker, E.R., Culler, S.D., and Ohsfeldt, R.L., “Impact of Board Certification on Physician Practice
Characteristics,” Journal of Medical Education, 60 [January 1985]: 9-15.
PUBLIC FINANCE/PUBLIC CHOICE McGuire, R.A. and Ohsfeldt, R.L., “Constitutional Economics and the Theory of Constitutional Choice,” in
Research in Law and Economics, Volume 18, R. Zerbe and V. Goldberg (eds.), Greenwich, Connecticut: JAI Press [1997]: 143-71.
McGuire, R.A. and Ohsfeldt, R.L., “The Impact of Taxes on the Privatization of Municipal Services,”
Economics Letters, 45 [August 1994]: 391-395.
McGuire, R.A., Ohsfeldt, R.L., and Van Cott, N.C., “More on the Choice between Public and Private
Production of a Publicly Funded Service,” Public Choice, 66 [August 1990]: 189-94.
McGuire, R.A. and Ohsfeldt, R.L., “Self-Interest, Agency Theory, and Political Voting Behavior: The
Ratification of the U.S. Constitution,” American Economic Review, 79 [March 1989]: 219-34. Reprinted in The International Library of Critical Writings in Economics: Constitutional Political Economy, S. Voigt (ed.), London: Edward Elgar Publishing, Ltd. [2003], Chapter 18.
McGuire, R.A. and Ohsfeldt, R.L., “Public Choice Analysis and the Ratification of the United States
Constitution,” in The Federalist Papers and the New Institutionalism, B. Grofman and D. Wittman (eds.), New York: Agathon Press [1989], Chapter 12, pp. 175-204.
McGuire, R.A., Ohsfeldt, R.L., and Van Cott, N.C., “The Determinants of the Choice Between Public and
Private Production of a Publicly Funded Service,” Public Choice, 54 [August 1987]: 211-30.
McGuire, R.A. and Ohsfeldt, R.L., “Public Versus Private Water Delivery: A Critical Analysis of a Hedonic
Cost Approach,” Public Finance Quarterly, 14 [July 1986]: 339-50.
McGuire, R.A. and Ohsfeldt, R.L., “An Economic Model of Voting Behavior Over Specific Issues at the
Constitutional Convention of 1787,” Journal of Economic History, 46 [March 1986]: 79-111.
McGuire, R.A. and Ohsfeldt, R.L., “Economic Interests and the American Constitution: A Quantitative
Rehabilitation of Charles A. Beard,” Journal of Economic History, 44 [June 1984]: 509-19.
URBAN/REGIONAL ECONOMICS Ohsfeldt, R.L. and Smith, B.A., “Calculating Elasticities from Structural Parameters in Implicit Markets,”
Journal of Urban Economics, 27 [March 1990]: 212-21.
Ohsfeldt, R.L., “Implicit Markets and the Demand for Housing Characteristics,” Regional Science and Urban Economics, 18 [August 1988]: 321-43. Reprinted in Modern Classics in Regional Science: Regional Housing and Labour Markets, M.M. Fischer et al. (eds.), London: Edward Elgar Publishing, Ltd. [1996].
Ohsfeldt, R.L. and Smith, B.A., “Assessing the Accuracy of Structural Parameter Estimates in Analyses of
Implicit Markets,” Land Economics, 64 [May 1988]: 135-46.
Ohsfeldt, R.L. and Smith, B.A., “Estimating the Demand for Heterogeneous Goods,” Review of Economics and Statistics, 67 [February 1985]: 165-71.
Ohsfeldt, R.L., “Specification of Block Rate Price Variables in Demand Models: Comment,” Land Economics, 59 [August 1983]: 365-369.
Ohsfeldt, R.L., “Efficiency and Interregional Factor Mobility: A Note,” Annals of Regional Science, 16 [July
Smith, B.A. and Ohsfeldt, R.L., “Housing Price Inflation in Houston: 1970-1976,” Policy Studies Journal, 8
[December 1979]: 257-76. Reprinted in Housing Policy for the 1980s, R. Montgomery and D. Marshall (eds.), Lexington, Massachusetts: D.C. Heath [1980], Chapter 7, pp. 89-111.
Books: Ohsfeldt, R.L., and Schneider, J.E., The Business of Health: The Role of Competition, Markets, and Regulation. Washington, DC: AEI Press, 2006.
Monographs and Published Reports (not peer-reviewed): Capilouto, E.I. and Ohsfeldt, R.L., “Health Workforce Modeling: Lessons from Dentistry,” The U.S. Health Workforce: Power, Politics, and Policy, M. Osterweis et al. (eds.), Washington, DC: Association of Academic Health Centers [1996], pp. 277-310.
Reynolds, R.A. and Ohsfeldt, R.L., editors, Socioeconomic Characteristics of Medical Practice 1984,
Chicago, Illinois: American Medical Association [August 1984], 140 pages.
Commentary/Editorials/Letters: Shaya, F.T. and Ohsfeldt, R.L., “Bridging the Gap between Pharmacoeconomics and the Real World Practice
of Managed Care Pharmacy,” Journal of Managed Care Pharmacy, 13 [January/February 2007]: 66-67.
Ohsfeldt, R.L., “Adverse Events Associated with Short-term Hormone Therapy (Letter),” Archives of Internal Medicine, 165 [March 14, 2005]: 587-88.
Ohsfeldt, R.L., “Challenges in Evaluating the Cost-Effectiveness of Statins,” Journal of Managed Care Pharmacy, 10 [January/February 2004]: 81-82.
Ohsfeldt, R.L., “If the ‘Business Model’ of Medicine is Sick, What’s the Diagnosis, and What’s the Cure?”
The Independent Review, 8 [Fall 2003]: 271-283.
Book Reviews: Healthy Competition: What’s Holding Back Health Care and How to Free It, by Michael F. Cannon and
Michael D. Tanner (Cato Institute, 2005, 171 pages), for The Independent Review 11 [Summer 2006]: 144-147.
Health Economics Worldwide, edited by Peter Zweifel and H.E. Frech III (Kluwer Academic Publishers
Group, 1991, 365 pages), for the Southern Economic Journal, 59 [April 1993]: 848-849.
Medicare's New Hospital Payment System: Is It Working?, by Louise B. Russell (Brookings Institution Press,
1989, 114 pages), for Inquiry, 27 [Winter 1990]: 390-391.
The Economics of Health Care: A Reference Handbook, by Michael Rosko and Robert Broyles (Greenwood
Press, 1988, 439 pages), for Inquiry, 26 [Fall 1989]: 407-408.
Advances in Health Economics and Health Services Research: Vol. 6, edited by Richard Scheffler and Louis
Rossiter (JAI Press, 1985, 286 pages), for the Journal of Health Administration Education, 6 [Winter 1988]: 144-146.
Beliefs About Inequality, by James R. Kluegel and Eliot R. Smith (Aldine Publishing Co., 1986, 332 pages),
for the Southern Economic Journal, 54 [October 1987]: 508-509.
CONFERENCE AND WORKSHOP PRESENTATIONS (Selected): “Explaining Differences in Life Expectancy Across Countries,” International Health Economics Association,
“A Comparison of Daily Average Supply (DASUP) of Oxycodone and Oxymorphone Long-Acting Oral
Tablets,” International Society for Pharmacoeconomics and Outcomes Research, Baltimore, Maryland [May 2011].
Economic Impact of Potential Drug-Drug Interactions Among Patients Taking Opioid Analgesics,”
International Society for Pharmacoeconomics and Outcomes Research, Baltimore, Maryland [May 2011].
“Payer-Rated Value of Pain Improvement in Castration-Resistant Prostate Cancer: Tradeoffs Between
Survival, Pain and Analgesic Use,” International Society for Pharmacoeconomics and Outcomes Research, Baltimore, Maryland [May 2011].
“Use of Secondary Data Sources to Estimate Inpatient Costs and Payments for Acute Coronary Syndrome,”
International Society for Pharmacoeconomics and Outcomes Research, Baltimore, Maryland [May 2011].
“Cost-effectiveness of Rosuvastatin 20 mg for the Prevention of Cardiovascular Morbidity and Mortality: A
Swedish Economic Evaluation of the JUPITER Trial,” European Society of Cardiology Congress, Stockholm, Sweden [August 2010].
“Cost-effectiveness of Rosuvastatin 20 mg in Reducing Cardiovascular Morbidity and Mortality in Patients at
Higher Risk of Cardiovascular Events,” American Heart Association Conference on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington, D.C. [May 2010].
“Cost-Effectiveness of Rosuvastatin 20 mg in Secondary-Prevention Patients in the United States,”
International Society for Pharmacoeconomics and Outcomes Research, Atlanta, Georgia [May 2010].
“Cost-Effectiveness of Rosuvastatin 10 mg in the Reduction of Cardiovascular Morbidity and Mortality in
Patients at Risk of Cardiovascular Disease,” International Society for Pharmacoeconomics and Outcomes Research, Atlanta, Georgia [May 2010].
“Medical and Economic Burden of Atherosclerosis among Older Patients,” American Heart Association
Conference on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington, D.C. [May 2009]
“Economic Burden of Atherosclerosis among Patients with Type 2 Diabetes Mellitus,” International Society
for Pharmacoeconomics and Outcomes Research, Orlando, Florida [May 2009].
“Diagnoses and Medical Management Patterns of Patients Prior to the Incidence of a Cardiovascular Event,”
American Heart Association Joint Conference, Cardiovascular Disease Epidemiology and Prevention & Nutrition, Physical Activity and Metabolism, Palm Harbor, FL [March 2009]
“Cardiovascular Events among Patients Diagnosed with Atherosclerosis,” American Heart Association Joint
Conference, Cardiovascular Disease Epidemiology and Prevention & Nutrition, Physical Activity and Metabolism, Palm Harbor, FL [March 2009]
“Clinical and Economic Burden of Atherosclerosis in Clinical Practice,” American Society of Health-Systems
Pharmacists, Orlando, Florida [December 2008].
“Differences in Resource Utilization among COPD Patients Treated with Albuterol MDI or Pirbuterol BAI,”
International Society for Pharmacoeconomics and Outcomes Research/European Congress, Athens, Greece [November 2008].
“Relationship Between Formal and Informal Care Among Medicaid Home Health Care Recipients,”
Gerontological Society of America, Washington, DC [November 2008].
“A Genetic Instrumental Variables Analysis of the Effects of Maternal Smoking on Birth Outcomes,”
American Society of Health Economists, Durham, North Carolina [June 2008].
“Low-density Lipoprotein Levels and Dyslipidemia Treatment in Patients Diagnosed With Atherosclerosis,”
American Heart Association/Quality of Care and Outcomes Research, Baltimore, Maryland [April 2008].
“Cost-Effectiveness Analysis of Atorvastatin, Rosuvastatin, and Simvastatin in Achieving Low-Density
Lipoprotein Cholesterol Goals in High-Risk Hypercholesterolemic Patients,” American Society of Health-Systems Pharmacists, Las Vegas, Nevada [December 2007].
“Prenatal Care Utilization and Its Effects on Infant Health in Samples of Normal versus Abnormal Births from
Argentina,” International Health Economics Association, Copenhagen, Denmark [July 2007].
“Effectiveness of Statins in LDL-C Lowering and National Cholesterol Education Program (NCEP) Adult
Treatment Panel (ATP) III Goal Attainment among Diabetes Patients,” American Diabetes Association, Chicago, Illinois [June 2007].
“Cost-Effectiveness among Brand and Generic Statins Based on Real-World Effectiveness: Implications for
Statin Formulary Design,” International Society for Pharmacoeconomics and Outcomes Research, Philadelphia, Pennsylvania [May 2007].
"Comparison of Titration Rates Among Statins in Routine Clinical Practice," American Heart Association,
Quality of Care Conference, Washington, DC [May 2007].
“Increased Risk of Cardiovascular Events Among Type 2 Diabetes Patients with Dyslipidemia,” American
Heart Association, Conference on Cardiovascular Disease Epidemiology and Prevention, Orlando, Florida [March 2007].
"Comparison of Low Density Lipoprotein-Cholesterol (LDL-C) Reduction After Switching Patients on Other
Statins to Rosuvastatin or Simvastatin in Real-World Clinical Practice Settings," American Society of Health-System Pharmacists, Anaheim, California [December 2006].
“Economic Impact of Specialty Hospitals,” Niche Hospital Study Forum, Texas Department of State Health
Services, Austin, Texas [November 2006].
“How Does the U.S. Healthcare System Compare to Healthcare Systems in Other Countries?” American
Enterprise Institute, Washington, DC [October 2006].
“Examining Titration Patterns with Statins in Routine Clinical Practice,” Academy of Managed Care
Pharmacy, Chicago, Illinois [October 2006].
“Annual Rates and Costs of Fragility Fractures by Gender in Managed Care Populations,” World Congress on
Osteoporosis, Toronto, Canada [June 2006].
“The Effects of Specialty Hospitals on General Hospital Operating Margins, 1997-2003,” American Society
of Health Economists, Madison, Wisconsin [June 2006].
“Rosuvastatin is More Cost-Effective Compared to Atorvastatin and Simvastatin for Hyperlipidemia
Management in High-Risk Patients in Routine Clinical Practice,” International Society for Pharmacoeconomics and Outcomes Research, Philadelphia, Pennsylvania [May 2006].
“Annual Costs of Fragility Fractures by Type and Age in Managed Care Populations,” European Calcified
Tissue Society, Prague, Czech Republic [May 2006].
“Effectiveness of Rosuvastatin Compared to Atorvastatin and Simvastatin in High-risk Patients in Routine
Clinical Practice,” Society of General Internal Medicine, Los Angeles, California [April 2006].
“The Institute for Healthcare Improvement (IHI) Saving 100K Lives Campaign: Are the Recommendations
for Stress Ulcer Prophylaxis (SUP) Cost Effective?” Society of Critical Care Medicine, San Francisco, California [January 2006].
“Cost-Effectiveness of Pharmacological Treatment for Osteopenia in Postmenopausal Women,” Society for
Medical Decision Making, San Francisco, California [October 2005].
“Treatment Innovation and the Costs of Treatment for Acute Coronary Syndrome,” American College of
Clinical Pharmacy, San Francisco, California [October 2005].
“Economic Evaluation of a Diabetes Education Program in Medicaid Patients,” American Association of
Diabetes Educators, Washington, DC [August 2005].
“Cost-Effectiveness of a Diabetes Education Program for Medicaid Patients,” American Diabetes Association,
“Impact of Treatment Improvements on Treatment Costs for Acute Coronary Syndrome,” 6th Scientific
Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington, D.C. [May 2005].
“Health Preferences and Willingness to Pay to Reduce Exposure to Post-Menopausal Risk Factors,”
International Society for Pharmacoeconomics and Outcomes Research, Washington, D.C. [May 2005].
“Potential Cost Savings from Acute Coronary Syndrome Treatment Improvements,” International Society for
Pharmacoeconomics and Outcomes Research, Washington, D.C. [May 2005].
“Cost-Effectiveness of Angiotensin-Receptor Blockers in Treating Mild-to-Moderate Hypertension,”
International Society for Pharmacoeconomics and Outcomes Research, Washington, D.C. [May 2004].
“Economic Evaluation of Short-Term Fracture-Related Costs Among Osteoporosis Treatments,” International
Society for Pharmacoeconomics and Outcomes Research, Washington, D.C. [May 2004].
“Fracture-Related Medical Costs in the First Year Following a Non-Vertebral Fracture in a Managed Care
Setting,” Academy of Managed Care Pharmacy, San Francisco, California [April 2004].
“Cost-Utility Analysis of Prenatal Genetic and Ultrasound Screening for Van der Woude Syndrome,”
American Cleft Palate-Craniofacial Association, Chicago, Illinois [March 2004].
“Albumin versus Crystalloid Therapy in the Management of Hepatorenal Syndrome: A Model for Using
Meta Analysis in Cost Effectiveness Studies and the Design of Clinical Trials,” American Medical Informatics Association, Washington, D.C. [November 2003].
“Cost Effectiveness of Prenatal Genetic and Ultrasound Screening for Van der Woude Syndrome,” American
Society of Human Genetics, Los Angeles, California [November 2003].
“Using Injury Information to Guide Prevention,” Fourth Annual Canadian Farm Safety and Health
Conference, Saskatoon, Saskatchewan [October 2003].
“Impact of Having a Young Child with Disabilities on Maternal Labor Supply,” International Conference on
Health Policy Research, Health Policy Statistics Section, American Statistical Association, Chicago, Illinois [October 2003].
"Patterns of Osteoporosis Therapy Use: Disease Severity, Patient Knowledge and Socioeconomic Factors,"
American Society for Bone and Mineral Research, Minneapolis, Minnesota [September 2003].
“Medical Care Costs Associated with Postmenopausal Estrogen-Progestin Therapy,” European Congress on
Rheumatology, Lisbon, Portugal [June 2003].
“Tamsulosin, Doxazosin or Terazosin as an Initial Drug Therapy for Benign Prostatic Hyperplasia: Cost-
Effectiveness from a Payer’s Perspective,” International Society for Pharmacoeconomics and Outcomes Research, Washington, D.C. [May 2003].
“Examining the Extent of ‘Loss-to-Follow-Up’ Among Postmenopausal Women Referred for Bone
Densitometry Screening with a DEXA-Confirmed Finding of Osteoporosis,” Society of General Internal Medicine, Vancouver, Canada [May 2003].
“Cost-Effectiveness of Tamsulosin, Doxazosin and Terazosin in the Treatment of Benign Prostatic
Hyperplasia,” American Urological Association, Chicago, Illinois [April 2003].
“Economic Barriers to Use of Colorectal Cancer Screening,” Iowa Colorectal Cancer Summit, Drake
University, Des Moines, Iowa [September 2002].
“Effects of Any Willing Provider and Freedom of Choice Laws on HMO Market Share,” Western Economic
Association, Seattle, Washington [June 2002].
“Cost of Agricultural Injuries and Occupational Diseases in Finland,” National Institute for Farm Safety,
“Issues in Evaluating Number Needed to Treat (NNT) Across Clinical Trials of Osteoporosis Treatment
Drugs,” American College of Rheumatology, San Francisco, California [November 2001].
“Trends in Diagnoses Associated with the Use of Raloxifene in the United States,” North American
Menopause Society, New Orleans, Louisiana [October 2001].
“Developing Useful Economic Models for Managed Care,” Progressive Strategies for Improved Formulary
Decisions, Academy of Managed Care Pharmacy, Dallas, Texas [October 2001].
“The Effects of Certificate-of-Need Repeal on Medicaid Long-Term Care Expenditures,” Academy for Health
Services Research and Health Policy, Atlanta, Georgia [June 2001].
“Impact of Postmenopausal Hormone Replacement Therapy on Resource Utilization and Costs,” Fourth
International Symposium on Women’s Health and Menopause, Washington, DC [May 2001].
“‘If I Was Buying a QALY, Maybe I’d Care How Much One Costs – But I’m Not So I Don’t’: Barriers to
Use of Cost-Effectiveness Information for Resource Allocation Decisions in Health Care,” Workshop, Institute of Government and Public Affairs, University of Illinois at Chicago [March 2001].
“Hormone Replacement Therapy in Postmenopausal Women: Utilization of Health Care Resources in New
Users,” South Atlantic Association of Obstetricians and Gynecologists, Hot Springs, Virginia [January 2001].
“Modeling the Annual Cost of Postmenopausal Osteoporosis Treatment Using Raloxifene, Bisphosphonates,
or Nasal Calcitonin,” American Society of Health-Systems Pharmacists, Las Vegas, Nevada [November 2000].
“Medical Care Costs Associated with Postmenopausal Hormone Replacement Therapy,” World Congress on
Osteoporosis, Chicago, Illinois [June 2000].
“Factors Associated With Hormone Replacement Therapy Utilization,” Academy of Managed Care Pharmacy,
“Modeling the Cost-Effectiveness of a New Pharmaceutical Agent for Formulary Decision Makers,” Lister
Hill Center for Health Policy Seminar Series, University of Alabama at Birmingham [November 1999].
“Modeling the Annual Cost of Postmenopausal Prevention Therapy using Hormone Replacement Therapy,
Raloxifene, or Alendronate,” North American Menopause Society, New York, New York [September 1999].
“Impact of Adverse Events Associated with Postmenopausal Hormone Replacement Therapy on Resource
Utilization,” International Society for Pharmacoeconomics and Outcomes Research, Washington, DC [May 1999].
“Impact of State Any Willing Provider Laws on Expenditures in Health Maintenance Organizations,”
Midwest Economics Association, Nashville, Tennessee [March 1999].
“Effects of Any Willing Provider and Freedom of Choice Laws on HMO Market Share,” Association for
Health Services Research, Washington, DC [June 1998].
“Issues in Developing Economic Models for Managed Care: The Case of Osteoporosis Prevention,”
International Society for Pharmacoeconomics and Outcomes Research, Philadelphia [May 1998].
“Health Care Use Among Women 45 and Older,” International Society for Pharmacoeconomics and
Outcomes Research, Philadelphia [May 1998].
“Factors Affecting the Spread of State ‘Any Willing Provider’ and ‘Freedom of Choice’ Laws,” Public
Choice Society, San Francisco [March 1997].
“Tobacco Taxes, Smoking Restrictions, and the Use of Cigarettes and Snuff,” National Bureau of Economic
Research, Conference on Behavioral Economics of Substance Abuse, Cambridge, Massachusetts [March 1997].
“Effects of Tobacco Excise Taxes and Smoking Restrictions on Patterns of Tobacco Use,” Western Economic
Association, San Francisco, California [July 1996].
“Unintended Pregnancy, Sample Selection, and Birth Outcomes,” Western Economic Association, San Diego,
“Effects of Hypothetical State Laws Proscribing Abortion on Measures of Infant Health: A Simulation
Analysis,” Allied Social Science Associations/American Economic Association, Washington, DC [January 1995].
“Tobacco Excise Taxes and Use of Smokeless Tobacco Products,” Southern Economic Association, Orlando,
“Unintended Pregnancy, Sample Selection, and Birth Outcomes,” Southern Demography Association,
“Comparison of Models Used to Forecast Supply and Demand for Physicians, Dentists, and Nurses,” Josiah
Macy, Jr. Foundation Workshop on Health Workforce Policy, Association of Academic Health Centers, Washington, DC [October 1994].
“Pregnancy Resolution Choice and Birth Outcomes,” American Public Health Association, San Francisco,
“State Parental Involvement Laws and Rates of Abortion and Fertility among Adolescent and Post-Adolescent
Women,” Western Economic Association, Lake Tahoe, Nevada [July 1993].
“Abortion, Unintended Fertility, and Measures of Infant Health,” Meeting of the Robert Wood Johnson
Foundation Faculty Fellows in Health Care Finance, Salt Lake City, Utah [March 1993].
“Impact of Abortion on Assessments of Unintended Fertility as a Risk Factor for Poor Birth Outcomes,”
Workshop on Health Services Research, Meharry Medical College, Nashville, Tennessee [October 1992].
“Do State Parental Involvement Laws Affect Abortion and Fertility Rates Among Adolescent Women?”
Southern Demography Association, Charleston, South Carolina [October 1992].
“Pregnancy Resolution Choice as a Sample Selection Problem in Evaluating Birth Outcomes,” Western
Economic Association, San Francisco, California [July 1992].
“The Demand for Abortions,” Western Economic Association, San Francisco, California [July 1992]. “The Effect of Price and Availability on Use of Abortion Services,” Midwest Economics Association,
“Effects of State Alcohol Taxes on Industrial Injury Rates,” Southern Economics Association, Nashville,
“Contractual Arrangements, Financial Incentives, and Physician-Patient Relationships,” Patient Care
Relationships and Ethics (multidisciplinary symposium funded by the American Sociological Association/National Science Foundation Fund for the Advancement of the Discipline), University of Alabama at Birmingham, Birmingham, Alabama [December 1990].
“State Regulation and Hospital Cost Performance: A Simultaneous Equations Approach,” Health Economics
Research Organization/American Economic Association, Atlanta, Georgia [December 1989].
“Effects of Prospective Payment on Medicaid Expenditures for Long Term Care,” Southern Economic
Association, San Antonio, Texas [November 1988].
“Economic and Political Factors Affecting Medicaid Payment Rates for Long Term Care,” Gerontological
Society of America, San Francisco, California [November 1988].
“Assessing the Accuracy of Structural Parameter Estimates in Analyses of Implicit Markets,” American Real
Estate and Urban Economics Association/ASSA, Dallas, Texas [December 1984].
“An Analysis of the Provision of Charity Medical Care by Physicians,” Public Policy Studies Workshop,
“Differences in Income Between Male and Female Physicians,” Joint Session of the Workshop on Health
Economics and Law and the Labor Economics Workshop, University of Wisconsin, Madison [September 1984].
“The Identification Problem in Implicit Markets,” Urban Economics Workshop, University of Chicago
FUNDED RESEARCH: Project Consultant, Identifying Determinants of Birth Outcomes in South America, Fogarty International
Investigator, Functional Outcomes in OEF/OIF Veterans with PTSD and Alcohol Misuse, Health Services
Research & Development, Department of Veterans Affairs, 1I01RX000304 [2010-2012]
Principal Investigator, Factors Motivating & Affecting Information Seeking in Health Information Exchange,
National Cancer Institute, R21-CA138605 [2009-2011].
Center for Health Organization Transformation, National Science Foundation
University/Industry Cooperative Research Center [2008-2013].
Investigator, Economic and Clinical Outcomes of Chronic Disease Management for Persons with Diabetes and CVD, Christus Foundation [2006-2008].
Investigator, Instant Total Contact Cast to Heal Diabetic Foot Ulcers, National Institute of Diabetes and
Digestive and Kidney Diseases [2006-2010].
Project Consultant, Economic Evaluation of 'Appropriate Foot Care', American Podiatric Medical
Investigator, Health and Health Services Use in the HRS/AHEAD, National Institute on Aging [2004-2009]. Investigator, Health Information Technology Value in Rural Hospitals, Agency for Healthcare Quality and
Investigator, Effectiveness of Care Coordination in Managing Medically Complex Patients, Health Services
Research & Development, Department of Veterans Affairs [2004-2005].
Investigator, Do Clinical Practice Guidelines Improve Economic Efficiency Within the VA System? Health
Services Research and Development, Department of Veterans Affairs [2003-06].
Principal Investigator, Development of a Model to Evaluate the Cost-Effectiveness of Tamsulosin in the Treatment of Benign Prostatic Hyperplasia, Boerhinger Ingelheim Pharmaceuticals, Inc. [2002].
Co-Principal Investigator, Impact of Payment Methods and Regulatory Structures on Patient Safety and Quality of Health Care, Iowa Department of Public Health/Centers for Disease Control [2002-03].
Co-Principal Investigator, Effects of ‘Any Willing Provider’ Laws on Prices and Managed Care Penetration,
Robert Wood Johnson Foundation, grant #029014 [1996-98].
Project Consultant, Managed Care and Hospital-Physician Integration, Agency for Health Care Policy and
Principal Investigator, Tobacco Excise Taxes, Smoking Regulations, and Risk of ST Use, National Cancer
Project Consultant, Effects of an ST Restrictive 'Worksite' Policy on ST-Related Behaviors, National Cancer
Co-Principal Investigator, Patterns of Eye Care Utilization among Older Women, Intramural Grant Program,
Lister Hill Center for Health Policy [1995-96].
Principal Investigator, Unintended Pregnancy and Risk of Low Birth Weight: The Role of Selectivity,
Substudy for UAB Low Birthweight PORT, contract HHS-282-92-0055, Agency for Health Care Policy and Research [1994-95].
Principal Investigator, The Effects of Tobacco Excise Taxes on the Use of Smokeless Tobacco Products,
Robert Wood Johnson Foundation, grant #23333 [1994].
Co-Principal Investigator, Rural Emergency Medical Services and Trauma Outcomes, Agency for Health
Care Policy and Research, R01-HS06814 [1993-94].
Investigator, Patient Outcomes Research Team (PORT), Low Birthweight in Minority and High Risk Women
(Health Care Systems Core), contract HHS-282-92-0055, Agency for Health Care Policy and Research [1992-97].
Co-Principal Investigator, Effects of Certificate-of-Need Regulation of Nursing Homes on State Medicaid Expenditures, Alabama State Medicaid Program [1991-92].
Project Consultant, Evaluation of Medicaid Waiver Program for Obstetrics Services in Alabama, Alabama
State Medicaid Program, contract with UAB Department of Health Care Organization and Policy [1991-92].
Principal Investigator, Determinants of Outcomes of Pregnancy, Agency for Health Care Policy and Research,
Project Consultant, Sentinel Counties Surveillance for Acute Viral Hepatitis and Epidemiology of Non-A, Non-B Hepatitis (Hepatitis C) Infection (Cost-Effectiveness Component), Centers for Disease Control, contract with Jefferson County (AL) Health Department [1990-94].
Co-Principal Investigator, Effects of State Alcohol Taxes on Industrial Injury, substudy for UAB Injury
Prevention Research Center, Centers for Disease Control, R49/CCR403641 [1990-91].
Project Consultant, Adolescent Sexually Transmitted Disease Project: Innovative Approaches to Clinical Care for STDs (Cost-Effectiveness Component), Centers for Disease Control, contract with UAB Department of Pediatrics and Jefferson County (AL) Health Department [1990-92]
Principal Investigator, An Implicit Market Model of Multiple Option Health Insurance Markets, Robert Wood
Johnson Foundation, grant #13791 [1989].
Project Consultant, Alternative Methods for Evaluating the Benefits of Improvements in Air Quality, U.S.
Environmental Protection Agency, subcontract with Center for Public Policy Studies, University of Chicago [1985].
Principal Investigator, An Econometric Analysis of the Demand for Housing Characteristics, U.S. Department
of Housing and Urban Development, H-5566-SG [1982-1983].
TEACHING ACTIVITIES: Courses Taught: Texas A&M Health Science Center
Health Economics I (Graduate), Cost-Effectiveness Analysis for Health Policy (Graduate), Health Insurance and Managed Care (Graduate), Health Delivery Systems Financing (Graduate), Analytic Issues in Health Services Research (Graduate)
Health Economics I (Graduate), Health Economics II (Graduate), Cost-Effectiveness and Decision Analysis in Health (Graduate), Analytic Issues in Health Services Research I (Graduate), Analytic Issues in Health Services Research II (Graduate)
Indiana University, School of Public and Environmental Affairs
Seminar in Health Services and Policy Research (guest speaker)
Health Economics (Graduate & Executive MSHA Program), Health and the Economics of Aging (Graduate), Advanced Health Economics (Graduate)
Health Economics (Undergraduate & Graduate), Cost Containment and Quality Assurance in Health Care (Graduate), Managerial Economics (Undergraduate), Principles of Microeconomics
Principles of Microeconomics & Macroeconomics, Intermediate Microeconomics, Managerial Economics (Graduate & Undergraduate), Mathematical Economics (Graduate & Undergraduate), Urban Economics (Undergraduate), Business Mathematics (Graduate), Business Statistics (Undergraduate)
Principles of Economics for Engineers (Undergraduate), Principles of Macroeconomics
Microeconomic Theory (for MBA Students), Principles of Microeconomics
Student Supervision: Member, Thesis Committee for Joshua Vest, Ph.D. Candidate (Health Services Research), Texas A&M
Member, Thesis Committee for Darci Moudouri, Ph.D. Candidate (Health Services Research), Texas A&M
Member, Thesis Committee for Patricia Moore, Ph.D. Candidate (Health Services Research), Texas A&M
Member, Thesis Committee for Margaret Kreigel, Ph.D. Candidate (Health Services Research), Texas A&M
Member, Thesis Committee for Pengxiang Li, Ph.D. Candidate (Health Management and Policy), University
Member, Thesis Committee for Sara Imhof, Ph.D. Candidate (Health Management and Policy), University of
Chair, Thesis Committee for George Wehby, Ph.D. Candidate (Health Management and Policy), University of
Member, Thesis Committee for Thomas Miller, Ph.D. Candidate (Health Management and Policy), University
Member, Thesis Committee for Gerd Clabaugh, Ph.D. Candidate (Health Management and Policy), University
Member, Thesis Committee for Gang Fang, M.S. Candidate (Pharmacy), University of Iowa [2004]. Member, Thesis Committee for Meagan Sheffer, Ph.D. Candidate (Public Health Dentistry), University of
Member, Thesis Committee for Lori Dolan, Ph.D. Candidate (Health Management and Policy), University of
Member, Thesis Committee for Mirou Jaana, Ph.D. Candidate (Health Management and Policy), University of
Member, Thesis Committee for Risto Rautiainen, Ph.D. Candidate (Occupational and Environmental Health),
Member, Thesis Committee for Qing Li, Ph.D. Candidate (Administration—Health), University of Alabama
Member, Thesis Committee for M. Gail Hill, Ph.D. Candidate (Administration—Health), University of
Residency Reviewer for Joan M. McMahon, MHSA Student, Arizona State University. Residency Site: St.
James Community Hospital, Butte, Montana [1986].
Member, Thesis Committee for Steven R. Kesslar, Ed.D. Candidate (Educational Administration), Ball State
SERVICE ACTIVITIES: Service to University Community: Texas A&M Health Science Center
Health Science Center, Appointments, Promotion and Tenure Committee [2007- ].
Health Science Center, Technology Commercialization Advisory Committee [2006-2009].
Health Science Center, Committee on Academic Salary History [2006-2007].
School of Rural Public Health, Search Committee for Department Chair – Epidemiology [2007-2008].
School of Rural Public Health, Nominations Committee [2006- ].
School of Rural Public Health, Research Committee [2006-2009].
School of Rural Public Health, Doctoral Degree Program Committee [2007- ; Chair, 2007-2009].
Department of Health Policy and Management, PhD Program Committee [2006- ; Chair, 2007-2009].
Department of Health Policy and Management, Faculty Search Committee [2007-08; 2008-09].
College of Public Health, Faculty Council [2004-2005]. College of Public Health, Promotion and Tenure Committee [2004-2005]. College of Public Health, Faculty Productivity Measurement Workgroup [2003-2005]. College of Public Health, Internal Departmental Review Committee, Department of Occupational and
College of Public Health, Internal Departmental Review Committee, Department of Epidemiology
College of Public Health, Biostatistics Department Head Search Committee [2001-2002]. Department of Health Management and Policy, Clinical-Track Faculty Review Advisory Committee
Department of Health Management and Policy, Promotion and Tenure Advisory Committee [2002-
School of Public and Environmental Affairs, MPH Curriculum Committee [1997-98].
University Committee on Undergraduate and Graduate Education in Gerontology [1990-96]. University Conflict of Interest Review Board [1995-97]. University Non-Academic Disciplinary Committee [1989-97]. School of Public Health, Admissions and Graduation Committee [1989-97; Chair, 1991-95]. School of Public Health, Faculty Affairs {i.e., Promotion & Tenure} Committee [1995-97]. School of Public Health, Incentives Work Group Faculty Salary Committee [Chair, 1995-96]. School of Public Health, Research Advisory Committee [1990-97]. Department of Health Care Organization & Policy, Faculty Search Committee [1991, 1993]. Department of Health Care Organization & Policy, Interim Department Chair [1997].
College of Business, Computer Resources Committee [1988-89]. College of Business, Research Committee [1986-87].
College of Business, Search Committee for Director of Bureau of Business Research [1984-85]. College of Business, Commencement Committee [1985-86]. College of Business, Computer Resources Committee [1984-85]. Department of Economics, Hiring Committee [1985-86]. Department of Economics, Curriculum Planning Committee [1982-83].
Service to Scholarly Community: Article Referee (ad hoc) American Economic Review American Journal of Economics & Sociology American Journal of Health-System Pharmacy Hospital & Health Services Administration Industrial and Labor Relations Review American Journal of Political Science International Journal for Quality in Health Care American Journal of Preventive Medicine International J of Health Care Finance & Economics Journal of the American Medical Association Cost-effectiveness and Resource Allocation Quarterly Review of Economics & Finance Review of Economics and Statistics Journal of Diabetes and Its Complications Journal of General Internal Medicine Topics in Geriatric Rehabilitation Vascular Health and Risk Management Journal of Health Politics, Policy & Law
Member, Selection Committee, Award for Excellence in Research Methodology, International Society
for Pharmacoeconomics and Outcomes Research [2004]
Grant Proposal Reviewer (ad hoc):
Small Grant Program, Agency for Health Care Policy and Research Intramural Grant Program, Lister Hill Center for Health Policy (UAB) Dissertation Research Grant Program, Agency for Health Care Policy and Research Robert Wood Johnson Foundation
Other Peer Review Activities (ad hoc):
MANIPUR LEGISLATIVE ASSEMBLY SECRETARIAT BULLETIN PART-I Friday, the 17th July, 2009. Asadha 26, 1931 (Saka) The House assembled at 11.00 am of Friday, the 17th July, 2009 in the Assembly Hall with the Hon’ble Speaker, Dr. S. Budhichandra Singh in the Chair. MEMBERS PRESENT: Hon’ble Chief Minister, 11 Cabinet Ministers, Chairman & Vice-Chairman(Hill Areas Committee) and 42
Zur Komorbidität von Aufmerksamkeitsdefizit/Hyperaktivitätssyndrom (ADHS) und Substanzstörungen Monika JOHANN*, Kirsten LANGE**, Susanne KÖNIG***, Rainer LAUFKÖTTER****, Willi UNGLAUB*****, Norbert WODARZ****** ZusammenfassungDas komorbide Auftreten eines Aufmerksamkeitsdefizit-/Hyperaktivitätssyn- droms (ADHS) wurde bei bis zu 1/3 der erwachsenen Kokainabhängigen ge-funden